Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional
Official Title: A Study of Safety and Efficacy of Leflunomide for Maintenance of Remission in IgG4 Related Disease
Brief Summary: The study has been designed as a 12-month, open-label, randomized, controlled study comparing the use of prednisone mono-therapy and prednisone and leflunomide combination therapy in treating patients with IgG4-related disease.